Skip to main content
Equibles

BAKER BROS. ADVISORS LP

Position in ALGS — Aligos Therapeutics, Inc.

CIK 1263508 NEW YORK, NY
Back to ALGS Full portfolio

Position in ALGS

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$479,227
-$137,871 QoQ
Shares Held
83,055
0.0% QoQ
Ownership
2.31%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#7
of 31 holders
Holding Since
Dec 2020
23 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in ALGS Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

BAKER BROS. ADVISORS LP holds $18,875,530,286 across 78 Biotechnology names. ALGS ranks #75 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 INCY
Incyte Corp
 30,762,330 $3,487,217,728
2 ONC
BeOne Medicines Ltd.
 8,801,567 $2,508,182,547
3 RVMD
Revolution Medicines, Inc.
 11,443,357 $2,143,111,898
4 MDGL
Madrigal Pharmaceuticals, Inc.
 2,143,131 $1,150,754,190
5 ACAD
Acadia Pharmaceuticals Inc
 42,912,904 $1,085,696,471
6 KYMR
Kymera Therapeutics, Inc.
 8,657,242 $992,725,940
7 INSM
INSMED Inc
 8,796,111 $937,841,354
8 CELC
Celcuity Inc.
 7,915,792 $828,150,159

All Filings in ALGS

Export CSV
23 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $479,227 83,055
2026-03-31 $617,098 83,055
2025-12-31 $774,072 83,055
2025-09-30 $813,939 83,055
2025-06-30 $598,826 83,055
2025-03-31 $685,203 83,055
2024-12-31 $3,308,911 83,055
2024-09-30 $719,256 83,055
2024-06-30 $726,740 2,076,400
2024-03-31 $2,034,872 2,076,400
2023-12-31 $1,378,729 2,076,400
2023-09-30 $1,551,070 2,076,400
2023-06-30 $2,016,184 2,076,400
2023-03-31 $1,814,773 2,076,400
2022-12-31 $1,978,809 2,076,400
2022-09-30 $2,284,040 2,076,400
2022-06-30 $2,512,444 2,076,400
2022-03-31 $4,464,260 2,076,400
2021-12-31 $24,646,868 2,076,400
2021-09-30 $32,204,964 2,076,400
2021-06-30 $32,819,850 1,610,000
2021-03-31 $36,611,400 1,610,000
2020-12-31 $44,516,500 1,610,000